The next big thing in diabetes : Clinical progress on DPP-IV inhibitorsVON GELDERN, Thomas W; TREVILLYAN, James M.Drug development research. 2006, Vol 67, Num 8, pp 627-642, issn 0272-4391, 16 p.Conference Paper

Structure-based virtual screening for low molecular weight chemical starting points for dipeptidyl peptidase IV inhibitorsWARD, Richard A; PERKINS, Tim D. J; STAFFORD, Jackie et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 22, pp 6991-6996, issn 0022-2623, 6 p.Article

Potent and selective proline derived dipeptidyl peptidase IV inhibitorsEDMONDSON, Scott D; MASTRACCHIO, Anthony; MARSILIO, Frank et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 20, pp 5151-5155, issn 0960-894X, 5 p.Article

Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitorsJINYOU XU; OK, Hyun O; WU, Joseph K et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 18, pp 4759-4762, issn 0960-894X, 4 p.Article

Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1MAGNIN, David R; TAUNK, Prakash C; ROBERTSON, James G et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 6, pp 1731-1734, issn 0960-894X, 4 p.Article

Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agentsJIN HEE AHN; KIM, Hye-Min; SUN HO JUNG et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 17, pp 4461-4465, issn 0960-894X, 5 p.Article

Carbon-14 labeling of Saxagliptin (BMS-477118)KAI CAO; BONACORSI, Samuel J; BALASUBRAMANIAN, Balu et al.Journal of labelled compounds & radiopharmaceuticals. 2007, Vol 50, Num 13-14, pp 1224-1229, issn 0362-4803, 6 p.Article

Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitorsBOEHRINGER, Markus; FISCHER, Holger; SEBOKOVA, Elena et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 3, pp 1106-1108, issn 0960-894X, 3 p.Article

Synthesis and biological evaluation of bicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetesTANG PENG CHO; LIN ZHI GANG; FENG JUN et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 12, pp 3521-3525, issn 0960-894X, 5 p.Article

Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitorsBETANCORT, Juan M; WINN, David T; XINQIANG LI et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4437-4440, issn 0960-894X, 4 p.Article

Discovery of Potent and Selective Dipeptidyl Peptidase IV Inhibitors Derived from β-Aminoaimdes Bearing Subsituted TriazolopiperazinesKIM, Dooseop; KOWALCHICK, Jennifer E; PATEL, Sangita B et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 3, pp 589-602, issn 0022-2623, 14 p.Article

Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitorsSATTIGERI, Jitendra A; ANDAPPAN, Murugaiah M. S; KISHORE, Kaushal et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 14, pp 4087-4091, issn 0960-894X, 5 p.Article

Discovery of long-acting N-(cyanomethyl)-N-alkyl-L-prolinamide inhibitors of dipeptidyl peptidase IVKONDO, Takashi; NEKADO, Takahiro; TODA, Masaaki et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 1, pp 190-208, issn 0968-0896, 19 p.Article

Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor designLIANG, Gui-Bai; XIAOXIA QIAN; XIAOPING ZHANG et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 13, pp 3706-3710, issn 0960-894X, 5 p.Article

Synthesis and biological evaluation of homopiperazine derivatives with β-aminoacyi group as dipeptidyl peptidase IV inhibitorsJIN HEE AHN; WOUL SEONG PARK; SUN YOUNG KIM et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 24, pp 6525-6529, issn 0960-894X, 5 p.Article

Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]-4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279) : A very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetesMADAR, David J; KOPECKA, Hana; BHAGAVATULA, Lakshmi et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 21, pp 6416-6420, issn 0022-2623, 5 p.Article

2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IVHAFFNER, Curt D; MCDOUGALD, Darryl L; TOMASZEK, Thaddeus et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 23, pp 5257-5261, issn 0960-894X, 5 p.Article

Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screeningCHEON, Hyae-Gyeong; LEE, Chul-Min; KIM, Beom-Tae et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 10, pp 2661-2664, issn 0960-894X, 4 p.Article

Synthesis and biological evaluation of azobicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetesTANG PENG CHO; YANG FANG LONG; LUO JING JING et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 12, pp 3565-3568, issn 0960-894X, 4 p.Article

(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone : A potent, selective, orally active dipeptidyl peptidase IV inhibitorAMMIRATI, Mark J; ANDREWS, Kim M; PARKER, Janice C et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 7, pp 1991-1995, issn 0960-894X, 5 p.Article

Synthesis and evaluation of structurally constrained imidazolidin derivatives as potent dipeptidyl peptidase IV inhibitorsLIUTANG WANG; BIN ZHANG; JIANXIN JI et al.European journal of medicinal chemistry. 2009, Vol 44, Num 8, pp 3318-3322, issn 0223-5234, 5 p.Article

Synthesis and biological evaluation of pyrazoline analogues with β-amino acyl group as dipeptidyl peptidase IV inhibitorsMI AE JUN; WOUL SEONG PARK; JIE OH LEE et al.European journal of medicinal chemistry. 2008, Vol 43, Num 9, pp 1889-1902, issn 0223-5234, 14 p.Article

Type 2 Diabetes and Oral Antihyperglycemic DrugsMIZUNO, Cassia S; CHITTIBOYINA, Amar G; KURTZ, Theodore W et al.Current medicinal chemistry. 2008, Vol 15, Num 1, pp 61-74, issn 0929-8673, 14 p.Article

(3R)-3-Amino-4-( 2,4,5 -trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-ylbutanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesNITTA, Aiko; FUJII, Hideaki; KUMAGAI, Hiroki et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 20, pp 5435-5438, issn 0960-894X, 4 p.Article

Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo durationKONDO, Takashi; NEKADO, Takahiro; TODA, Masaaki et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 7, pp 2631-2650, issn 0968-0896, 20 p.Article